Fentanyls and Naloxone. Opioids, Overdose, and Naloxone

Similar documents
WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

Street Fentanyl and its Analogues What Pharmacists Need to Know. Welcome We will begin shortly.

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

OPIOIDS. Testing and Interpretation

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Otterbein Police Department. Opioid Addition Awareness

Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar. July-16-18

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

GOALS AND OBJECTIVES

Heroin. Brain Research Institute, UCLA Alison Taylor

LESSON ASSIGNMENT. After completing this lesson, you should be able to: Given a group of definitions, select the definition of analgesia.

Expert Peer Review for Carfentanil

Clinical pharmacological aspects of heroin and fentanyl overdoses

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

Heroin What You Need to Know

Grand Rapids Police Department

Buprenorphine pharmacology

Take Home Naloxone elearning Module Script

5/29/2015. Responding to the Opioid Crisis. Responding to the Opioid Crisis. Objectives

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Opioids - Fentanyl - Naloxone. Public Health Nurse

Buprenorphine Access in California

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Take Home Naloxone: What Pharmacists Need to Know

Emerging Drug Threat April 09, 2018

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose

Sierra Sacramento Valley EMS Agency

Lieutenant John Harless Mississippi Bureau of Narcotics

Vermont's Opioid Crisis and Response to the Crisis

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

DREAM MARKET DATA BY NOVEL SYNTHETIC OPIOID CATEGORIES COMPARISON TO ARCHIVED AGORA DATA

FENTANYL AND CARFENTANIL EXPOSURE IN PARAMEDIC SERVICES

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates

Buprenorphine as a Treatment Option for Opioid Use Disorder

HEALTHCARE AND THE OPIOID EPIDEMIC DAN MUSE, MD SIGNATURE HEALTHCARE-BROCKTON HOSPITAL

Fentanyl Fact and Fiction: The Rise of America s Narcotic Crisis. Dan

Methadone Maintenance

3/26/14. Opiates PSY B396 ALCOHOL, ALCOHOLISM, & DRUG ABUSE. Early History Cont d. Early History. Opiate Use in the 19th century. Technology Advances

Officer Al Fear Eastern Iowa Heroin Initiative Cedar Rapids Police Department U.S. Attorney s Office NDIA

Dr Alistair Dunn. General Practitioner Whangarei

Pharmacology of Selected Opioid Analgesics

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Trends in Opioid Availability and Abuse DEA Philadelphia Field Division April 2018

8/28/2017. Headlines. How Did We Get Here? Pain is the number one reason patients go the doctors office, urgent care and/or emergency room.

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE

Module II Opioids 101 Opiate Opioid

Choose a category. You will be given the answer. You must give the correct question. Click to begin.

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone

Opioid Toxicity - Objectives. Opioid Toxicity: A Poison Center. and Pediatric Perspective. Greatest Increase is Exposures

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:

MODUS OPERANDI FENTANYL. Control No.: P-693/

Medication Assisted Treatment. Michael Palladini, RPh MBA CAC

12/14/2018. Disclosures. Buprenorphine. Drug-Receptor Interactions. Affinity

Latest Press Release. How much for 30 mg adderall

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Acute Pain NETP: SEPTEMBER 2013 COHORT

Drug Trends &Trafficking I/S Brian Dempsey

Prescription Opioids

Prescription Opioid Addiction

Pharmacology of Selected Opioid Analgesics

Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

Disclosure Statement. Learning Objectives. American Psychiatric Nurses Association. Christian J. Teter, PharmD, BCPP 1 BUPRENORPHINE UPDATE

Fentanils in Europe: perspective from the EU EWS

Primer on Synthetic Opioids I/S Brian Dempsey

Frontline Florida: Emerging Drug Trends The Opiate Epidemic

The Opioid Crisis URBAN FIRE FORUM SEPTEMBER 20-22, 2017

Opioids Research to Practice

Back in a few minutes Geoff

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN

Fentanyls. Reference materials LGC Quality ISO 9001 ISO/IEC ISO Guide 34 GMP/GLP ISO ISO/IEC 17043

Steven Prakken MD Director Medical Pain Service Duke Pain Medicine

Side-effects of opioids what are they, are they common, and how do I deal with them?

Let s Talk About. Pain Medicines. wisconsin. health literacy. A division of Wisconsin Literacy, Inc.

9/13/2017. Buprenorphine Treatment (Suboxone) Disclosures. We ve Got a Big Opioid Problem. Selahattin Kurter, MD Spectrum Healthcare

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Opioids and Overdose 2017

Substances under Surveillance

Karam Darwish. Dr. Munir. Munir Gharaibeh

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Analgesics OPIOID ANALGESICS

USE OF BUPRENORPHINE FOR CHRONIC PAIN

Opioid Harm Reduction

Opioids. Sergio Hernandez, MD

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM

National Council on Patient Information and Education

Lisa Booze, PharmD, CSPI

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

Opioids and Chronic Pain: Case studies and Personal Experience

Transcription:

Opioids, Overdose, and Naloxone

Presenter Disclosure Presenter s Name: Michael Beazely I have no current or past relationships with commercial entities Speaking Fees for current program: I have received a speaker s fee from McKesson for this learning activity (not personally, but to the University of Waterloo)

Commercial Support Disclosure This program has received no financial or in-kind support from any commercial or other organization

Outline: Opioid refresher Opioid overdose Illicit fentanyls Non-fentanyl illicit opioids Potency, purity, product, administration, and analysis Naloxone mechanism of action

What is an opioid?: Any chemical that activates opioid receptors can be described as an opioid: - chemicals produced in the human brain - chemicals found in nature, - modified versions of natural opioids - fully synthetic chemicals

What is an opioid receptor?: A protein found in many cell types, including brain cells, that interacts with opioids and mediates their effects The three main types of opioid receptors are: μ Mu δ Delta κ Kappa image.slidesharecdn.com/opioidreceptorsopioidanalgesics-160618124306/95/opioid-receptors-its-analgesics-23-638.jpg?cb=1466254016

What do opioids do?: Activation of opioid receptors leads to: - relief of pain and altered pain perception - sedation and anesthesia - cough suppression - constipation/treatment of diarrhea - miosis (small pupils) - euphoria - tolerance, dependence, addiction - nausea and vomiting - sweating - respiratory depression

What do opioids do?: Activation of opioid receptors leads to: - relief of pain and altered pain perception - sedation and anesthesia - cough suppression - constipation/treatment of diarrhea - miosis (small pupils) - euphoria - tolerance, dependence, addiction - nausea and vomiting - sweating - respiratory depression

What do opioids do?: Activation of opioid receptors leads to: - relief of pain and altered pain perception - sedation and anesthesia - cough suppression - constipation/treatment of diarrhea - miosis (small pupils) - euphoria - tolerance, dependence, addiction - nausea and vomiting - sweating - respiratory depression http://images.medicaldaily.com/sites/medicaldaily.com/files/styles/headline/public/2015/12/18/heroin.jpg

Fentanyls and Naloxone What do opioids do?: Activation of opioid receptors leads to: - relief of pain and altered pain perception - sedation and anesthesia - cough suppression - constipation/treatment of diarrhea - miosis (small pupils) - euphoria - tolerance, dependence, addiction - nausea and vomiting - sweating - respiratory depression https://upload.wikimedia.org/wikipedia/commons/f/f0/occhi222.jpg

What do opioids do?: Activation of opioid receptors leads to: - relief of pain and altered pain perception - sedation and anesthesia - cough suppression - constipation/treatment of diarrhea - miosis (small pupils) - euphoria - tolerance, dependence, addiction - nausea and vomiting - sweating - respiratory depression https://lh5.googleusercontent.com/x18lx7tc3bdy

https://lh5.googleusercontent.com/x18lx7tc3bdy

Respiratory centre: The respiratory centre controls breathing without conscious control When oxygen levels fall (and carbon dioxide levels start to rise) the respiratory centre causes you to breath more and rapidly When oxygen and CO2 levels normalize breathing slows

Opioid receptors in the respiratory centre: At high doses, opioids interfere with respiratory centre function Over-activation of opioid receptors make the respiratory centre less and less sensitive to rising carbon dioxide levels in the blood Breathing becomes less frequent, more shallow, and ultimately stops during an opioid overdose

Illicit fentanyls: Fentanyl is a potent opioid, used in anesthesia, for pain, chronic pain, pain in end of life care Typically administered as a patch placed on the skin Illicit fentanyls ( bootleg ) include fentanyl itself, and up to 35 chemically-related, but distinct fentanyl analogues

https://www.google.ca/url?sa=i&rct=j&q=&esrc=s&source=images&cd

Illicit fentanyls in Canada/US: fentanyl, acrylfentanyl, beta-hydroxythiofentanyl, thenylfentanyl, 3-methylfentanyl, acetylfentanyl, butyrfentanyl, furanfentanyl, carfentanil What we know: - variability in potency, all have opioid activity What we don t know: - definitive human potency, duration of action, metabolism, metabolite activities, unique actions and toxicities

Non-fentanyl illicit opioids in Canada/US: U-47700, AH-7921, MT-45 (confirmed) What we know: - these were drugs in the pharma pipeline, we know a considerable amount about their preclinical info - slightly more potent than therapeutic opioids, less potent than fentanyls What we don t know: - definitive human potency, duration of action, metabolism, metabolite activities, unique actions and toxicities

Opioid Effective Dose* (pure product) Lethal Dose* Morphine 10 mg 200 mg Fentanyl 0.1 mg 2 mg Carfentanil 0.001 mg 0.02 mg *in an opioid-naive patient, i.e. no tolerance

Purity and product: Imported pure fentanyl is diluted, typically to 2-3% or less of a bulk powder, sold as powder or pressed into pills It is sold as: Fentanyl Heroin Counterfeit pharmaceutical opioids (demerol, percocet, oxycontin) Has appeared in: Cocaine Methamphetamine MDMA

Routes of administration: Oral Transdermal Sublingual Buccal Insufflation Inhalation Intravenous Rectal It is unclear whether there are differences between fentanyls with respect to their bioavailability

Fentanyls and Naloxone Fentanyl detection: Testing for fentanyl (point of care urine, lab analysis) was designed for pharmaceuticalgrade fentanyl These tests may, or may not, cross-react with fentanyl analogues These test may, or may not, be sensitive enough to detect very low amounts (e.g. carfentanil)

Overdose reversal by naloxone: All opioids are opioid receptor AGONISTS (binds and activates the receptor) Naloxone is opioid receptor ANTAGONIST (binds, but does not activate the receptor) naloxone morphine

Opioid overdose: Lots of opioid over-activating the opioid receptors

Naloxone reverses the overdose: By competing for opioid receptors and kicking off the opioid

Naloxone doesn t last long: Naloxone is metabolized faster than opioid agonists

Naloxone metabolism: As naloxone levels fall, but the opioid remains, the overdoes could return

Affinity and concentration: Receptor affinities for opioids and naloxone are similar carfentanil > fentanyl = naloxone > morphine > oxycodone (Depending on the concentration!), you would predict that more naloxone would be required to reverse a carfentanil vs. fentanyl vs. morphine overdose

Unanswered questions: Is intranasal naloxone more effective than IM injections in the field How likely are intranasal naloxone or high-dose IM injections to cause severe withdrawal, including agitation and possible aggression, compared to standard IM doses? How can we distribute the right naloxone product and dose to the right patient?

Contact information: Michael Beazely Associate Professor School of Pharmacy, University of Waterloo mbeazely@uwaterloo.ca 519-888-4567 x21310